RxDoctor Payments Data

Anastasia Koss, DPM

Podiatrist · Dayton, OHNPI 1316357858

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,623 of the $6,388 with a category attached, or 88.0%. 31 manufacturers reported payments, led by Smith+Nephew at 27.6% of the total.

$6,388in general payments, 2019–2025

Across 146 payments — averaging $43.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$2K
  • Paragon 28, Inc.$1K
  • Kerecis Limited$697
  • Access Pro Medical, LLC$320
  • Organogenesis Inc.$250
  • Paratek Pharmaceuticals, Inc.$232
  • plus $2K from 25 others

What the payments were for

  • Travel & lodging$76512%
  • Food & beverage$5,62388%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,388 in reported general payments places this provider in the 85th percentile of 397 podiatrist providers in Ohio.

See all podiatrist providers in Ohio

Medicare billing

Part B allowed, 2024
$66,830
Medicare patients
170
Services billed
858

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Doxycycline Hyclate39$323
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav12$90
Ciprofloxacin Hcl13$85
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim17$71

Paid to pharmacies, not to this prescriber.

Other podiatrist in Dayton

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →